Role of fibrin matrix in angiogenesis

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 426-437

  Van Hinsbergh, Victor W M ^a   Collen, Annemie ^b   Koolwijk, Pieter ^b  

^a TNO   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Angiogenesis; Blood vessels; Fibrin matrix; Fibrinous stoma; Wound healing

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; FIBRIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MATRIX METALLOPROTEINASE; PLASMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL INVASION; CONFERENCE PAPER; ENDOTHELIUM CELL; FEMALE GENITAL SYSTEM; FIBRIN DEPOSITION; HYPOXIA; INFLAMMATORY CELL; LEUKOCYTE; MICROVASCULARIZATION; NEOVASCULARIZATION (PATHOLOGY); PH; TISSUE REPAIR; WOUND HEALING;

EID: 0034968332     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03526.x     Document Type: Conference Paper

References (44)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Angiogenesis in cancer and other diseases
3. Arteriogenesis, the good and bad of it
4. Transgenic mouse models in angiogenesis and cardiovascular disease
5. Tumor angiogenesis
6. Treatment of diabetic retinopathy
7. Angiogenesis and rheumatoid arthritis - Pathogenic and therapeutic implications
8. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing
9. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells
10. Manipulating angiogenesis - From basic science to the bedside
11. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border
12. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
13. Fibronectin controls capillary endothelial cell growth by modulating cell shape
14. Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
15. Regulation of angiogenesis in vitro
16. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression
17. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: Implications for capillary-like tube formation in a fibrin matrix
18. Transforming growth factor-β-1 modulates basic fibroblast growth factor induced proteolytic and angiogenic properties of endothelial cells in vitro
19. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells
20. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
21. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
22. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells - Effects of tumor necrosis factor-alpha, interleukin-1 and phorbol ester
23. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells - Regulation by tumor necrosis factor-alpha and doxycycline
24. Mechanisms for pro matrix metalloproteinase activation
25. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
26. Physiological consequences of loss of plasminogen activator gene function in mice
27. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
28. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice
29. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
30. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions
31. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels
32. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration
33. Transglutaminase activity of the fibrin crosslinking enzyme
34. Cross-link in fibrin polymerized by factor 13: Epsilon-(gamma-glutamyl)lysine
35. Monoclonal antibody directed to a fibrinogen A alpha #529-539 epitope inhibits alpha-chain crosslinking by transglutaminases
36. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
37. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro
38. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
39. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation
40. Role of integrin alpha(v)beta3 in vascular biology
41. Alternative adhesion sites in human fibrinogen for vascular endothelial cells
42. Organized type I collagen influences endothelial patterns during "spontaneous angiogenesis in vitro": Planar cultures as models of vascular development
43. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
44. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis